Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Re-evaluating early breast neoplasia.

Sharon Moulis1, Dennis C Sgroi

  • 1Department of Pathology, Harvard Medical School, Molecular Pathology Research Unit, Massachusetts General Hospital, Boston, Massachusetts 02129, USA.

Breast Cancer Research : BCR
|February 19, 2008
PubMed
Summary

Atypical ductal hyperplasia and ductal carcinoma in situ were thought to be the earliest breast cancer stages. Molecular analyses reveal multiple distinct pathways of breast cancer evolution, changing our understanding of early neoplastic lesions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Weak supervision of H&E slides reveals systems-level biology and functional states that govern therapeutic resistance.

bioRxiv : the preprint server for biology·2026
Same author

ERBB2/HOXB13 co-amplification with interstitial loss of BRCA1 defines a unique subset of breast cancers.

Breast cancer research : BCR·2024
Same author

Case 27-2024: A 24-Year-Old Man with Pain and Dyspnea.

The New England journal of medicine·2024
Same author

Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial.

Clinical cancer research : an official journal of the American Association for Cancer Research·2024
Same author

Atypical cystic hypersecretory lesions of the breast commonly harbour TP53 alterations.

Histopathology·2023
Same author

Correlative studies of the Breast Cancer Index (HOXB13/IL17BR) and ER, PR, AR, AR/ER ratio and Ki67 for prediction of extended endocrine therapy benefit: a Trans-aTTom study.

Breast cancer research : BCR·2022

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Histomorphological and epidemiological data previously identified atypical ductal hyperplasia and ductal carcinoma in situ as the earliest neoplastic stages of breast cancer.
  • These early lesions are crucial for understanding the initiation and progression of breast cancer.

Purpose of the Study:

  • To re-evaluate the earliest stages of breast cancer progression using modern molecular techniques.
  • To understand the molecular heterogeneity and distinct evolutionary pathways in early breast cancer.

Main Methods:

  • High-throughput molecular genetic analyses
  • Gene expression profiling
  • Epigenetic analyses

Main Results:

Related Experiment Videos

  • Detailed molecular analyses have significantly enhanced the understanding of early neoplastic lesions in the breast.
  • The study revealed multiple distinct molecular pathways driving breast cancer evolution, challenging the traditional linear progression model.

Conclusions:

  • The progression of breast cancer is more complex than previously thought, involving multiple distinct evolutionary pathways.
  • Modern molecular techniques provide a deeper insight into the heterogeneity of early neoplastic lesions and their role in cancer development.